Epigenetic Regulation of Estrogen signaling in Breast Cancer

Estrogen prolonged exposure, combined with high levels of hormone increases the risk of breast cancer by constitutively activating the transcription of genes predominantly implicated in metabolism and cell cycle regulation

The NCBI advances science and health by providing access to biomedical and genomic information.

Estrogen signaling is mediated by ERα and ERβ in hormone dependent, breast cancer (BC). Over the last decade the implication of epigenetic pathways in BC tumorigenesis has emerged: cancer-related epigenetic modifications are implicated in both gene expression regulation, and chromosomal instability. In this review, the epigenetic-mediated estrogen signaling, controlling both ER level and ER-targeted gene expression in BC, are discussed: (1) ER silencing is frequently observed in BC and is often associated with epigenetic regulations while chemical epigenetic modulators restore ER expression and increase response to treatment;(2) ER-targeted gene expression is tightly regulated by co-recruitment of ER and both coactivators/corepressors including HATs, HDACs, HMTs, Dnmts and Polycomb proteins.


Have your say! Share your views